ID   MEL15765
AC   CVCL_C7UH
SY   15765 mel
DR   Wikidata; Q123033034
RX   PubMed=22207316;
RX   PubMed=23849826;
CC   Derived from site: Metastatic; Liver; UBERON=UBERON_0002107.
DI   NCIt; C7712; Uveal melanoma
DI   ORDO; Orphanet_39044; Uveal melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 29-06-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=22207316; DOI=10.1007/s00262-011-1179-z; PMCID=PMC3401505;
RA   Mazzarella T., Cambiaghi V., Rizzo N., Pilla L., Parolini D.,
RA   Orsenigo E., Colucci A., Modorati G., Doglioni C., Parmiani G.,
RA   Maccalli C.;
RT   "Ex vivo enrichment of circulating anti-tumor T cells from both
RT   cutaneous and ocular melanoma patients: clinical implications for
RT   adoptive cell transfer therapy.";
RL   Cancer Immunol. Immunother. 61:1169-1182(2012).
//
RX   PubMed=23849826; DOI=10.1016/j.ejca.2013.06.011;
RA   Amaro A., Mirisola V., Angelini G., Musso A., Tosetti F.I.,
RA   Esposito A.I., Perri P., Lanza F.B., Nasciuti F., Mosci C., Puzone R.,
RA   Salvi S., Truini M., Poggi A., Pfeffer U.;
RT   "Evidence of epidermal growth factor receptor expression in uveal
RT   melanoma: inhibition of epidermal growth factor-mediated signalling
RT   by gefitinib and cetuximab triggered antibody-dependent cellular
RT   cytotoxicity.";
RL   Eur. J. Cancer 49:3353-3365(2013).
//